Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran

Abstract

Background: The epidemiology of inflammatory bowel disease (IBD) is changing globally and there is disagreement between studies about the prevalence of relapse of ulcerative colitis (UC) as a type of IBD.

A study on the potential role of autophagy‐related protein 10 as a biomarker for ulcerative colitis

“…

Ulcerative colitis (UC) and Crohn's disease (CD), classified as inflammatory bowel diseases (IBD), are lifelong diseases, arise from an interaction between genetic and environmental factors, and are predominantly observed in developed countries (Hosseini et al, 2016). They are increasing worldwide with the increasing pace of the westernization of societies.

…”

Ulcerative colitis: a phytomedical technical note

“…Inflammatory bowel disease (IBD) consists of two similar but distinct diseases including ulcerative colitis (UC) and Crohn's disease (CD) (Hosseini et al 2016). The etiology of UC is not clearly known and some different reasons such as immune system dysfunction, genetic susceptibility, changes in the gut flora, and environmental factors may be involved Tanideh et al 2017).…”

Pathophysiological role of Atg5 in human ulcerative colitis

“…Changing of lifestyle increases the prevalence of multifactorial and chronic diseases, such as inflammatory bowel disease (IBD), in different manners. 1 IBD is characterized by idiopathic inflammation of the gastrointestinal (GI) tract and has 2 main types, ulcerative colitis (UC) and Crohn' s disease (CD). 2,3 UC is a costly disease and imposes a heavy direct and indirect burden on populations.…”